{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:49:14Z","timestamp":1761166154217,"version":"build-2065373602"},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.anndiagpath.2021.151730","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T13:11:00Z","timestamp":1616073060000},"page":"151730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Additional characterization of LEF1 expression in nodular lymphocyte predominant Hodgkin lymphoma and classic Hodgkin lymphoma"],"prefix":"10.1016","volume":"52","author":[{"given":"Bryan","family":"Rea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathanael G.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2021.151730_bb0005","doi-asserted-by":"crossref","first-page":"151636","DOI":"10.1016\/j.anndiagpath.2020.151636","article-title":"Lymphoid enhancer binding factor 1 (LEF1) expression is significantly higher in Hodgkin lymphoma associated with Richter syndrome relative to de novo classic Hodgkin lymphoma","volume":"49","author":"Lyapichev","year":"2020","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151730_bb0010","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2011.103","article-title":"Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia\/small lymphocytic lymphoma in small B-cell lymphomas","volume":"11","author":"Tandon","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151730_bb0015","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/jclinpath-2015-202862","article-title":"LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia\/small lymphocytic B cell lymphoma","volume":"68","author":"Menter","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151730_bb0020","first-page":"292","article-title":"Diagnostic utility of lymphoid enhancer binding factor 1 immunohistochemistry in small B-cell lymphomas","volume":"147","author":"Menter","year":"2017","journal-title":"Am J Clin Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:32:52Z","timestamp":1761078772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913421000307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":4,"alternative-id":["S1092913421000307"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151730","relation":{},"ISSN":["1092-9134"],"issn-type":[{"type":"print","value":"1092-9134"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Additional characterization of LEF1 expression in nodular lymphocyte predominant Hodgkin lymphoma and classic Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151730"}}